Department of Otolaryngology, Hospital Universitario La Paz, IdiPAZ Research Institute, 28046 Madrid, Spain.
Biomedical Research Networking Centre on Rare Diseases (CIBERER), Institute of Health Carlos III, CIBERER-U761, 28029 Madrid, Spain.
Int J Environ Res Public Health. 2023 Jun 22;20(13):6201. doi: 10.3390/ijerph20136201.
Although it is a recognized phenomenon, there is little published in the literature on the discontinuation of auditory implant use. To evaluate the incidence of device non-use of transcutaneous auditory implants. : This is a retrospective study of all living individuals (children and adults) implanted at the La Paz Hospital (Madrid, Spain) between 1992-2015, with a follow-up examination endpoint of December 2022. 356 device recipients were included: 316 with cochlear implants (CI), 22 with middle-ear implants (Vibrant Soundbridge, VSB), and 18 with bone conduction implants (Bonebridge, BB). Nine CI recipients (2.8%) were identified as non-users (mean follow-up 15.1 ± 5.4 years). The reasons for non-use were implant failure and reimplantation rejection, lack of benefit, non-attendance of rehabilitation sessions, loss of the audio processor, and cognitive and linguistic difficulties. None of them experienced any surgical complications. Six VSB recipients (27.3%) were device non-users (mean follow-up 11.4 ± 2.1 years). All of them experienced device failure or surgical complications. To date, none of the BB recipients is a non-user (mean follow-up 8.6 ± 1.1 years). The rates of non-use of transcutaneous auditory implants vary widely between different types of implants. Given the small proportion of non-users, information on what are the predictive factors could not be determined. The reasons for non-use should be carefully documented and used to guide careful patient selection to reduce the risk of non-use in future candidates.
尽管这是一种公认的现象,但文献中关于听觉植入物停用的报道很少。评估经皮听觉植入物的设备不使用率。这是一项对 1992 年至 2015 年间在拉帕兹医院(西班牙马德里)植入的所有存活个体(儿童和成人)进行的回顾性研究,随访终点为 2022 年 12 月。共纳入 356 名设备受者:316 名接受耳蜗植入物(CI),22 名接受中耳植入物(Vibrant Soundbridge,VSB),18 名接受骨导植入物(Bonebridge,BB)。9 名 CI 受者(2.8%)被确定为非使用者(平均随访 15.1 ± 5.4 年)。不使用的原因是植入物失败和再植入排斥、缺乏受益、未参加康复课程、音频处理器丢失以及认知和语言困难。他们中没有人经历过任何手术并发症。6 名 VSB 受者(27.3%)为设备非使用者(平均随访 11.4 ± 2.1 年)。他们都经历过设备故障或手术并发症。迄今为止,没有一名 BB 受者是非使用者(平均随访 8.6 ± 1.1 年)。不同类型植入物的经皮听觉植入物不使用率差异很大。鉴于非使用者的比例较小,无法确定哪些是预测因素的信息。不使用的原因应仔细记录并用于指导患者的仔细选择,以降低未来候选者不使用的风险。